![Neil Josephson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Josephson
Chief Tech/Sci/R&D Officer at
IAMBIC THERAPEUTICS, INC.
Net worth: 1 M $ as of 29/09/2026
Profile
Dr. Neil Josephson, MD, is a Chief Medical Officer at Iambic Therapeutics, Inc. and an Associate Professor-Medicine at Bloodworks Northwest.
Dr. Josephson was previously employed as a Chief Medical Officer by Zymeworks BC, Inc., a Chief Medical Officer by Zymeworks, Inc., and a Vice President-Clinical Development by Seattle Genetics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from Columbia University Irving Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/10/2026 | 71,459 ( 0.15% ) | 1 M $ | 29/09/2026 |
Neil Josephson active positions
| Companies | Position | Start |
|---|---|---|
| IAMBIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2023 |
Bloodworks Northwest
 Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Corporate Officer/Principal | - |
Former positions of Neil Josephson
| Companies | Position | End |
|---|---|---|
| ZYMEWORKS INC. | Chief Tech/Sci/R&D Officer | 02/01/2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Chief Tech/Sci/R&D Officer | 31/12/2022 |
| SEAGEN INC. | Corporate Officer/Principal | 31/12/2018 |
Education of Neil Josephson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bloodworks Northwest
Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Health Services |
Columbia University Medical Center
 Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
 Entos, Inc. BiotechnologyHealth Technology Operates as a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Neil Josephson
